Search Results - "KREIL, Sebastian"
-
1
Functional imaging with dual-energy computed tomography for supplementary non-invasive assessment of mast cell burden in systemic mastocytosis
Published in Scientific reports (20-08-2022)“…Systemic mastocytosis (SM) is characterized by multifocal accumulation of neoplastic mast cells (MCs), predominately affecting the bone marrow (BM). Imaging…”
Get full text
Journal Article -
2
Adverse Prognostic Impact of the KIT D816V Transcriptional Activity in Advanced Systemic Mastocytosis
Published in International journal of molecular sciences (04-03-2021)“…In systemic mastocytosis (SM), qualitative and serial quantitative assessment of the D816V mutation is of diagnostic and prognostic relevance. We investigated…”
Get full text
Journal Article -
3
Multidrug‐resistant organisms in allogeneic hematopoietic cell transplantation
Published in European journal of haematology (01-05-2017)“…Objective Multidrug‐resistant organisms (MDRO) are a challenge in allogeneic hematopoietic cell transplantation (HCT). However, in the literature there is no…”
Get full text
Journal Article -
4
Somatic Diseases in Child Survivors of the Holocaust With Posttraumatic Stress Disorder: A Comparative Study
Published in The journal of nervous and mental disease (01-05-2012)“…ABSTRACTThe incidence of mental and somatic sequelae has been shown to be very high in people who survived the Holocaust. In the current study, 80 Holocaust…”
Get full text
Journal Article -
5
Dynamics of BCR-ABL mutated clones prior to hematologic or cytogenetic resistance to imatinib
Published in Haematologica (Roma) (01-02-2008)“…III. Medizinische Klinik, Medizinische Fakultät Mannheim der Universität Heidelberg, Mannheim, Germany Correspondence: Andreas Hochhaus, III. Medizinische…”
Get full text
Journal Article -
6
Dynamics of mutant BCR-ABL-positive clones after cessation of tyrosine kinase inhibitor therapy
Published in Haematologica (Roma) (01-03-2011)“…Point mutations of the BCR-ABL tyrosine kinase domain are considered the predominant cause of imatinib resistance in chronic myeloid leukemia. The expansion of…”
Get full text
Journal Article -
7
A polymorphism associated with STAT3 expression and response of chronic myeloid leukemia to interferon α
Published in Haematologica (Roma) (01-01-2010)“…Interferon alpha (IFN) induces variable responses in chronic myeloid leukemia (CML), with 8-30% of early chronic phase cases achieving a complete cytogenetic…”
Get full text
Journal Article -
8
Perfusion Imaging with SPECT in the Era of Pathophysiology-Based Biomarkers for Alzheimer's Disease
Published in International journal of alzheimer's disease (2010)“…SPECT allows registration of regional cerebral blood flow (rCBF) which is altered in a characteristic temporoparietal pattern in Alzheimer's Dementia. Numerous…”
Get full text
Journal Article -
9
Prospective analysis of the attendance behaviour of the participants of a facilitated support group for patients after allogeneic hematopoietic cell transplantation
Published in Supportive care in cancer (01-01-2024)“…Purpose Support groups might help survivors of allogeneic hematopoietic cell transplantations (HCT) to cope with medical, psychological, and social challenges…”
Get full text
Journal Article -
10
Superior Efficacy of Midostaurin Over Cladribine in Advanced Systemic Mastocytosis: A Registry-Based Analysis
Published in Journal of clinical oncology (01-06-2022)“…On the basis of data from the German Registry on Disorders of Eosinophils and Mast Cells, we compared the efficacy of midostaurin and cladribine in patients…”
Get full text
Journal Article -
11
Response and Resistance to Cladribine in Patients with Advanced Systemic Mastocytosis: A Registry-Based Analysis
Published in Blood (15-11-2022)Get full text
Journal Article -
12
Antibody Response to Vaccination with BNT162b2, mRNA-1273, and ChADOx1 in Patients with Myeloid and Lymphoid Neoplasms
Published in Blood (23-11-2021)“…Background: In general, patients with hematological diseases are predisposed to develop infections. Severe COVID-19 infection associated with high mortality is…”
Get full text
Journal Article -
13
Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: reevaluation of the defining characteristics in a registry-based cohort
Published in Leukemia (01-09-2023)“…In a registry-based analysis of 135 patients with “myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions” (MLN-TK; FIP1L1::PDGFRA , n …”
Get full text
Journal Article -
14
Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms
Published in Blood (11-06-2009)“…Recent evidence has demonstrated that acquired uniparental disomy (aUPD) is a novel mechanism by which pathogenetic mutations in cancer may be reduced to…”
Get full text
Journal Article -
15
-
16
The insertion site is the main risk factor for central venous catheter‐related complications in patients with hematologic malignancies
Published in American journal of hematology (01-03-2022)“…Central venous catheters (CVC) placed either via the internal jugular vein (IJV) or the subclavian vein (SCV) are routinely used in patients with hematologic…”
Get full text
Journal Article -
17
-
18
Hematopoietic stem-cell transplantation for advanced systemic mastocytosis
Published in Journal of clinical oncology (10-10-2014)“…Advanced systemic mastocytosis (SM), a fatal hematopoietic malignancy characterized by drug resistance, has no standard therapy. The effectiveness of…”
Get full text
Journal Article -
19
Clinical and histopathological features of myeloid neoplasms with concurrent Janus kinase 2 (JAK2) V617F and KIT proto‐oncogene, receptor tyrosine kinase (KIT) D816V mutations
Published in British journal of haematology (01-07-2021)“…Summary We report on 45 patients with myeloid neoplasms and concurrent Janus kinase 2 (JAK2) V617F and KIT proto‐oncogene, receptor tyrosine kinase (KIT) D816V…”
Get full text
Journal Article -
20
Response and resistance to cladribine in patients with advanced systemic mastocytosis: a registry-based analysis
Published in Annals of hematology (01-08-2023)“…We sought to evaluate the efficacy of the purine analogue cladribine in 79 patients with advanced systemic mastocytosis (AdvSM) using data from the ‘German…”
Get full text
Journal Article